HIV-1 tat interacts with and regulates the localization and processing of amyloid precursor protein

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Kim, Jiyoung ^a   Yoon, Jee Hyun ^a   Kim, Yeon Soo ^a  

^a Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA C TERMINAL FRAGMENT; AMYLOID PRECURSOR PROTEIN; BETA C TERMINAL FRAGMENT; BETA SECRETASE; GAMMA SECRETASE; PRESENILIN 1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LIPID RAFT; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SUCROSE DENSITY GRADIENT CENTRIFUGATION; ANIMAL; CELL LINE; CELL MEMBRANE; GENETICS; HIPPOCAMPUS; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSGENIC MOUSE;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL LINE; HIPPOCAMPUS; HIV-1; HUMANS; MEMBRANE MICRODOMAINS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN TRANSPORT; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84896723007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077972     Document Type: Article

References (71)

1. Huigen MC, Kamp W, Nottet HS (2004) Multiple effects of HIV-1 transactivator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 34: 57-66. (Pubitemid 38221740)
2. SenGupta DN, Berkhout B, Gatignol A, Zhou AM, Silverman RH (1990) Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 87: 7492-7496. (Pubitemid 20341742)
3. Braddock M, Thorburn AM, Chambers A, Elliott GD, Anderson GJ, et al. (1990) A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell 62: 1123-1133.
4. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, et al. (1996) The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 2: 1371-1375. (Pubitemid 26401742)
5. Lotz M, Clark-Lewis I, Ganu V (1994) HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J Cell Biol 124: 365-371. (Pubitemid 24050354)
6. Milani D, Mazzoni M, Borgatti P, Zauli G, Cantley L, et al. (1996) Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J Biol Chem 271: 22961-22964. (Pubitemid 26314724)
7. King JE, Eugenin EA, Buckner CM, Berman JW (2006) HIV tat and neurotoxicity. Microbes Infect 8: 1347-1357. (Pubitemid 43842005)
8. Ma M, Nath A (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499. (Pubitemid 27078635)
9. Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, et al. (2001) HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288: 301-308. (Pubitemid 33022484)
10. Kruman, II, Nath A, Mattson MP (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276-288. (Pubitemid 29044201)
11. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, et al. (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 95: 3117-3121. (Pubitemid 28135864)
12. Andras IE, Pu H, Deli MA, Nath A, Hennig B, et al. (2003) HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 74: 255-265. (Pubitemid 37193712)
13. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736. (Pubitemid 17054046)
14. Cras P, Perry G (1991) Dementia with argyrophilic grains. Ann Neurol 30: 853-854.
15. Annaert W, De Strooper B (2002) A cell biological perspective on Alzheimer's disease. Annu Rev Cell Dev Biol 18: 25-51. (Pubitemid 35387344)
16. Weidemann A, Paliga K, Durrwang U, Reinhard FB, Schuckert O, et al. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 274: 5823-5829. (Pubitemid 29109238)
17. Lin X, Koelsch G, Wu S, Downs D, Dashti A, et al. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A 97: 1456-1460. (Pubitemid 30118462)
18. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390. (Pubitemid 28093512)
19. Caporaso GL, Takei K, Gandy SE, Matteoli M, Mundigl O, et al. (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. J Neurosci 14: 3122-3138.
20. Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389. (Pubitemid 24218009)
21. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, De Candia P, et al. (1997) Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J Biol Chem 272: 6399-6405. (Pubitemid 27118118)
22. Mueller HT, Borg JP, Margolis B, Turner RS (2000) Modulation of amyloid precursor protein metabolism by X11alpha/Mint-1. A deletion analysis of protein-protein interaction domains. J Biol Chem 275: 39302-39306. (Pubitemid 32058950)
23. Taru H, Iijima K, Hase M, Kirino Y, Yagi Y, et al. (2002) Interaction of Alzheimer's beta -amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade. J Biol Chem 277: 20070-20078. (Pubitemid 34967531)
24. Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW (2006) DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem 281: 35176-35185. (Pubitemid 46036557)
25. Lee J, Retamal C, Cuitino L, Caruano-Yzermans A, Shin JE, et al. (2008) Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes. J Biol Chem 283: 11501-11508.
26. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, et al. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 102: 13461-13466. (Pubitemid 41420870)
27. Hiltunen M, Lu A, Thomas AV, Romano DM, Kim M, et al. (2006) Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion. J Biol Chem 281: 32240-32253. (Pubitemid 46036778)
28. Zhang C, Saunders AJ (2009) An emerging role for Ubiquilin 1 in regulating protein quality control system and in disease pathogenesis. Discov Med 8: 18-22.
29. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, et al. (2000) Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275: 7410-7415. (Pubitemid 30146296)
30. Herz J, Strickland DK (2001) LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784. (Pubitemid 32880284)
31. Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19: 127-135. (Pubitemid 40409531)
32. Giunta B, Zhou Y, Hou H, Rrapo E, Fernandez F, et al. (2008) HIV-1 TAT Inhibits Microglial Phagocytosis of Abeta Peptide. Int J Clin Exp Pathol 1: 260-275.
33. Giunta B, Hou H, Zhu Y, Rrapo E, Tian J, et al. (2009) HIV-1 Tat Contributes to Alzheimer's Disease-like Pathology in PSAPP Mice. Int J Clin Exp Pathol 2: 433-443.
34. Ulich C, Dunne A, Parry E, Hooker CW, Gaynor RB, et al. (1999) Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription. J Virol 73: 2499-2508. (Pubitemid 29098157)
35. Kaniowska D, Kaminski R, Amini S, Radhakrishnan S, Rappaport J, et al. (2006) Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J Virol 80: 9288-9299. (Pubitemid 44360001)
36. Saunders M, Eldeen MB, Del Valle L, Reiss K, Peruzzi F, et al. (2005) p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes. Apoptosis 10: 1419-1431. (Pubitemid 43117686)
37. Aprea S, Del Valle L, Mameli G, Sawaya BE, Khalili K, et al. (2006) Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci 26: 4054-4062. (Pubitemid 44315426)
38. Parkin ET, Turner AJ, Hooper NM (1999) Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem J 344 Pt 1: 23-30.
39. Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 100: 11735-11740. (Pubitemid 37206004)
40. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, et al. (2004) Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279: 44945-44954. (Pubitemid 39430908)
41. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160: 113-123. (Pubitemid 36091721)
42. Rushworth JV HN (2011) Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis 2011: 603052.
43. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, et al. (1997) Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 272: 13793-13802. (Pubitemid 27225457)
44. Oakley H, Cole SL, Logan S, Maus E, Shao P, et al. (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26: 10129-10140. (Pubitemid 44527407)
45. Hioki H, Kameda H, Nakamura H, Okunomiya T, Ohira K, et al. (2007) Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther 14: 872-882. (Pubitemid 46780070)
46. Shiomura Y, Hirokawa N (1987) Colocalization of microtubule-associated protein 1A and microtubule-associated protein 2 on neuronal microtubules in situ revealed with double-label immunoelectron microscopy. J Cell Biol 104: 1575-1578. (Pubitemid 17104526)
47. Green DA ME, Vinters HV, Beizai P, Moore DJ, Achim CL. (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19: 407-411. (Pubitemid 40446187)
48. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, et al. (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 42: 34-40. (Pubitemid 27304778)
49. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM (1997) Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol 93: 184-189. (Pubitemid 27060912)
50. Chen L, Choi JJ, Choi YJ, Hennig B, Toborek M (2012) HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits. Neurobiol Aging 33: 1579-1590.
51. Green AJ, Giovannoni G, Hall-Craggs MA, Thompson EJ, Miller RF (2000) Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease. Sex Transm Infect 76: 443-446. (Pubitemid 32055921)
52. Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M (1999) Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci 171: 92-96.
53. Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65: 1490-1492. (Pubitemid 41552790)
54. Levy-Dweck S (2005) HIV/AIDS fifty and older: a hidden and growing population. J Gerontol Soc Work 46: 37-50.
55. Anthony IC RS, Carnie FW, Simmonds P, Bell JE (2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111: 529-538. (Pubitemid 43778957)
56. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, et al. (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6: 1380-1387. (Pubitemid 32001023)
57. Aksenov MY, Aksenova MV, Mactutus CF, Booze RM (2010) HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett 475: 174-178.
58. Kittiworakarn J, Lecoq A, Moine G, Thai R, Lajeunesse E, et al. (2006) HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers. J Biol Chem 281: 3105-3115. (Pubitemid 43845920)
59. Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, et al. (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci 29: 1977-1986.
60. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, et al. (2005) Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 11: 434-439. (Pubitemid 40562335)
61. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291. (Pubitemid 16013975)
62. Kim SY, Lee JH, Shin HS, Kang HJ, Kim YS (2002) The human elongation factor 1 alpha (EF-1 alpha) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter. J Biotechnol 93: 183-187.
63. Vetrivel KS, Zhang X, Meckler X, Cheng H, Lee S, et al. (2008) Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta. J Biol Chem 283: 19489-19498.
64. Refolo LM, Wittenberg IS, Friedrich VL, Jr., Robakis NK (1991) The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J Neurosci 11: 3888-3897.
65. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, et al. (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198: 1398-1406.
66. Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, et al. (2004) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc Natl Acad Sci U S A 101: 17510-17515. (Pubitemid 39657434)
67. Crozet C, Lin YL, Mettling C, Mourton-Gilles C, Corbeau P, et al. (2004) Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. J Cell Sci 117: 5591-5597. (Pubitemid 40012205)
68. Ory DS, Neugeboren BA, Mulligan RC (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 93: 11400-11406. (Pubitemid 26347133)
69. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267. (Pubitemid 26119138)
70. Harris B, Pereira I, Parkin E (2009) Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res 1296: 203-215.
71. Valvatne H, Szilvay AM, Helland DE (1996) A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation. AIDS Res Hum Retroviruses 12: 611-619. (Pubitemid 26120293)